1. Home
  2. CLRB vs REBN Comparison

CLRB vs REBN Comparison

Compare CLRB & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • REBN
  • Stock Information
  • Founded
  • CLRB 2002
  • REBN 2015
  • Country
  • CLRB United States
  • REBN United States
  • Employees
  • CLRB N/A
  • REBN N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • CLRB Health Care
  • REBN Consumer Discretionary
  • Exchange
  • CLRB Nasdaq
  • REBN Nasdaq
  • Market Cap
  • CLRB 12.8M
  • REBN 13.3M
  • IPO Year
  • CLRB N/A
  • REBN 2022
  • Fundamental
  • Price
  • CLRB $3.36
  • REBN $1.84
  • Analyst Decision
  • CLRB Hold
  • REBN
  • Analyst Count
  • CLRB 2
  • REBN 0
  • Target Price
  • CLRB N/A
  • REBN N/A
  • AVG Volume (30 Days)
  • CLRB 321.2K
  • REBN 84.6K
  • Earning Date
  • CLRB 10-31-2025
  • REBN 11-14-2025
  • Dividend Yield
  • CLRB N/A
  • REBN N/A
  • EPS Growth
  • CLRB N/A
  • REBN N/A
  • EPS
  • CLRB N/A
  • REBN N/A
  • Revenue
  • CLRB N/A
  • REBN $6,565,623.00
  • Revenue This Year
  • CLRB N/A
  • REBN $335.98
  • Revenue Next Year
  • CLRB N/A
  • REBN N/A
  • P/E Ratio
  • CLRB N/A
  • REBN N/A
  • Revenue Growth
  • CLRB N/A
  • REBN 14.03
  • 52 Week Low
  • CLRB $3.17
  • REBN $1.03
  • 52 Week High
  • CLRB $66.00
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 32.40
  • REBN 28.84
  • Support Level
  • CLRB $3.70
  • REBN $2.14
  • Resistance Level
  • CLRB $4.10
  • REBN $2.37
  • Average True Range (ATR)
  • CLRB 0.32
  • REBN 0.14
  • MACD
  • CLRB -0.08
  • REBN -0.03
  • Stochastic Oscillator
  • CLRB 9.69
  • REBN 1.45

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: